Cambridge Healthtech Institute’s Second Annual
Emerging Peptide Therapeutics
Discovery, Engineering, Design, and Delivery
May 13-14, 2027
Peptide drug discovery is experiencing a surge of interest and scientific momentum with this class of compounds making headlines daily, and peptide therapeutics are playing a pivotal role in addressing unmet medical needs. The Second Annual Emerging Peptide Therapeutics conferenc at PEGS Boston on May 13-14 covers discovery, engineering, and design in this exciting area and will feature half-life extended peptides, GLP-1 agonists, and applications in and beyond obesity and diabetes. Hear about engineering, format, and delivery advances being made to allow peptides to compete and combine with complex modalities.
Coverage will include, but is not limited to:
- Designing novel peptides with extended half-life and enhanced drug-like properties
- Investigating novel routes of delivery
- Targeting indications in diabetes, obesity, metabolic diseases, cardiovascular, and Alzheimer’s disease
- Addressing intracellular targets
- Generating novel cyclic and macrocyclic peptides
- Leveraging AI and computationally-guided design of peptides
- Exploring peptide structure prediction using AI/ML technologies
The deadline for priority consideration is October 23, 2026.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation:
- To submit a podium presentation, please click here.
- To become a sponsor, click here.
- To present a poster, click here.
- To sign up to attend, click here.